Reports - Alpha Emitter Market
HealthcareAlpha Emitter Market
Alpha Emitter Market Growth and Trends | Insights & Forecast 2025-2035 by Radionuclide (Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, Others) by Application (Prostate Cancer, Bone Metastases, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, Others) by Sources (Natural Sources, Artificially produced sources) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Alpha Emitter Market - Segment Analysis
1. Overview
2. Global Alpha Emitter Market, 2021 - 2035 (USD Million)
3. Global Alpha Emitter Market - by Radionuclide
3.1. By Radium (Ra-223)
3.2. By Actinium (Ac-225)
3.3. By Lead (Pb-212)
3.4. By Astatine-211
3.5. By Bismuth-213
3.6. By Others
4. Global Alpha Emitter Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastases
4.3. By Ovarian Cancer
4.4. By Pancreatic Cancer
4.5. By Endocrine Tumors
4.6. By Others
5. Global Alpha Emitter Market - by Sources
5.1. By Natural Sources
5.2. By Artificially produced sources
6. Global Alpha Emitter Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Alpha Emitter Market - Segment Analysis
1. Overview
2. North America Alpha Emitter Market, 2021 - 2035 (USD Million)
3. North America Alpha Emitter Market - by Radionuclide
3.1. By Radium (Ra-223)
3.2. By Actinium (Ac-225)
3.3. By Lead (Pb-212)
3.4. By Astatine-211
3.5. By Bismuth-213
3.6. By Others
4. North America Alpha Emitter Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastases
4.3. By Ovarian Cancer
4.4. By Pancreatic Cancer
4.5. By Endocrine Tumors
4.6. By Others
5. North America Alpha Emitter Market - by Sources
5.1. By Natural Sources
5.2. By Artificially produced sources
Chapter 5 Europe Alpha Emitter Market - Segment Analysis
1. Overview
2. Europe Alpha Emitter Market, 2021 - 2035 (USD Million)
3. Europe Alpha Emitter Market - by Radionuclide
3.1. By Radium (Ra-223)
3.2. By Actinium (Ac-225)
3.3. By Lead (Pb-212)
3.4. By Astatine-211
3.5. By Bismuth-213
3.6. By Others
4. Europe Alpha Emitter Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastases
4.3. By Ovarian Cancer
4.4. By Pancreatic Cancer
4.5. By Endocrine Tumors
4.6. By Others
5. Europe Alpha Emitter Market - by Sources
5.1. By Natural Sources
5.2. By Artificially produced sources
Chapter 6 Asia Pacific Alpha Emitter Market - Segment Analysis
1. Overview
2. Asia Pacific Alpha Emitter Market, 2021 - 2035 (USD Million)
3. Asia Pacific Alpha Emitter Market - by Radionuclide
3.1. By Radium (Ra-223)
3.2. By Actinium (Ac-225)
3.3. By Lead (Pb-212)
3.4. By Astatine-211
3.5. By Bismuth-213
3.6. By Others
4. Asia Pacific Alpha Emitter Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastases
4.3. By Ovarian Cancer
4.4. By Pancreatic Cancer
4.5. By Endocrine Tumors
4.6. By Others
5. Asia Pacific Alpha Emitter Market - by Sources
5.1. By Natural Sources
5.2. By Artificially produced sources
Chapter 7 Latin America Alpha Emitter Market - Segment Analysis
1. Overview
2. Latin America Alpha Emitter Market, 2021 - 2035 (USD Million)
3. Latin America Alpha Emitter Market - by Radionuclide
3.1. By Radium (Ra-223)
3.2. By Actinium (Ac-225)
3.3. By Lead (Pb-212)
3.4. By Astatine-211
3.5. By Bismuth-213
3.6. By Others
4. Latin America Alpha Emitter Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastases
4.3. By Ovarian Cancer
4.4. By Pancreatic Cancer
4.5. By Endocrine Tumors
4.6. By Others
5. Latin America Alpha Emitter Market - by Sources
5.1. By Natural Sources
5.2. By Artificially produced sources
Chapter 8 Middle East & Africa Alpha Emitter Market - Segment Analysis
1. Overview
2. Middle East & Africa Alpha Emitter Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Alpha Emitter Market - by Radionuclide
3.1. By Radium (Ra-223)
3.2. By Actinium (Ac-225)
3.3. By Lead (Pb-212)
3.4. By Astatine-211
3.5. By Bismuth-213
3.6. By Others
4. Middle East & Africa Alpha Emitter Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastases
4.3. By Ovarian Cancer
4.4. By Pancreatic Cancer
4.5. By Endocrine Tumors
4.6. By Others
5. Middle East & Africa Alpha Emitter Market - by Sources
5.1. By Natural Sources
5.2. By Artificially produced sources
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Actinium Pharmaceutical Inc.
2. Alpha Tau Medical Ltd
3. Bayer AG
4. Bracco
5. Cardinal Health
6. Eckert & Ziegle
7. Fusion Pharmaceuticals
8. IBA Worldwide
9. NorthStar Medical Radioisotopes (NMR)
10. Orano Group
11. Viewpoint Molecular Targeting
12. RadioMedix
13. Telix Pharmaceuticals Limited.
14. TerraPower
15. LLC
16. NIOWAVE Inc. and IONETIX Corporation.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By